Magnetar Financial LLC Has $161.10 Million Stock Holdings in Sanofi (NASDAQ:SNY)

Magnetar Financial LLC raised its stake in shares of Sanofi (NASDAQ:SNY) by 104.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,340,317 shares of the company’s stock after purchasing an additional 1,705,148 shares during the quarter. Sanofi accounts for about 3.8% of Magnetar Financial LLC’s holdings, making the stock its biggest holding. Magnetar Financial LLC owned approximately 0.13% of Sanofi worth $161,103,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also bought and sold shares of the stock. Boston Partners lifted its position in Sanofi by 86.4% during the fourth quarter. Boston Partners now owns 5,396,531 shares of the company’s stock valued at $260,607,000 after purchasing an additional 2,501,073 shares during the last quarter. Franklin Resources Inc. lifted its holdings in shares of Sanofi by 13.1% in the 3rd quarter. Franklin Resources Inc. now owns 3,407,452 shares of the company’s stock worth $208,106,000 after acquiring an additional 395,744 shares during the last quarter. Natixis Advisors LLC lifted its holdings in shares of Sanofi by 1.2% in the 4th quarter. Natixis Advisors LLC now owns 2,910,021 shares of the company’s stock worth $140,350,000 after acquiring an additional 35,828 shares during the last quarter. Raymond James Financial Inc. bought a new stake in shares of Sanofi in the 4th quarter worth approximately $135,933,000. Finally, JPMorgan Chase & Co. lifted its holdings in shares of Sanofi by 20.9% in the 3rd quarter. JPMorgan Chase & Co. now owns 2,310,809 shares of the company’s stock worth $133,172,000 after acquiring an additional 399,301 shares during the last quarter. 14.04% of the stock is currently owned by institutional investors.

Sanofi Stock Down 0.9 %

Shares of NASDAQ SNY opened at $58.60 on Thursday. The company has a quick ratio of 1.14, a current ratio of 1.46 and a debt-to-equity ratio of 0.15. Sanofi has a 52 week low of $45.22 and a 52 week high of $60.12. The firm’s fifty day moving average is $54.22 and its 200 day moving average is $52.89. The company has a market cap of $148.72 billion, a price-to-earnings ratio of 23.53, a PEG ratio of 1.01 and a beta of 0.58.

Sanofi (NASDAQ:SNY) last issued its earnings results on Thursday, January 30th. The company reported $0.70 EPS for the quarter, hitting the consensus estimate of $0.70. Sanofi had a net margin of 12.77% and a return on equity of 25.61%. On average, equities research analysts expect that Sanofi will post 4.36 earnings per share for the current year.

Wall Street Analyst Weigh In

SNY has been the subject of a number of recent research reports. StockNews.com lowered shares of Sanofi from a “buy” rating to a “hold” rating in a report on Thursday, December 12th. Sanford C. Bernstein upgraded shares of Sanofi to a “strong-buy” rating in a report on Thursday, January 30th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Sanofi from a “sell” rating to a “hold” rating in a report on Thursday, January 30th. Two research analysts have rated the stock with a hold rating, one has given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $60.00.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.